Trial · NCT02558296
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in HbA1c From Baseline to Week 24 | 24 weeks | Number of subjects with a value at baseline and at Week 24. | percentage of glycated hemoglobin | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in HbA1c at Week 24 for Subjects Who Have Been Prescribed Insulin | 24 weeks | Number of subjects with a value at baseline and at week 24. | Percentage of HbA1c | LEAST_SQUARES_MEAN |
| SECONDARY | Change in Body Weight From Baseline to Week 48 | 48 weeks | Number of subjects with a value at baseline and at Week 48 is included. | kg | LEAST_SQUARES_MEAN |
| SECONDARY | Change in Systolic Blood Pressure From Baseline to Week 24 in Subjects Hypertensive at Baseline | 24 weeks | Number of subjects with a value at baseline and at week 24 | mm Hg | LEAST_SQUARES_MEAN |
| OTHER_PRE_SPECIFIED | Change in HbA1c From Baseline Over Time | Baseline (week 0) and weeks 6, 12, 24, 36, 48, 72, 96, 120, 144 and 168 | Number of subjects with a value at baseline and at the specified visit. | Percentage of HbA1c | LEAST_SQUARES_MEAN |
| OTHER_PRE_SPECIFIED | Change in Fasting Plasma Glucose Over Time | Baseline (week 0) and weeks 6, 12, 24, 36, 48, 72, 96, 120, 144 and 168 | Number of subjects with a value at baseline and at the specified visit. | mmol/L | LEAST_SQUARES_MEAN |
| OTHER_PRE_SPECIFIED | Proportion of Subjects Requiring an Intensification of Hypoglycemic Agent and Time to First Intensification | 24 week | Proportion of participants | NUMBER | |
| OTHER_PRE_SPECIFIED | Proportion of Subjects Requiring an Intensification of Hypoglycemic Agent and Time to First Intensification | Duration of study (168 weeks) | Proportion of participants | NUMBER | |
| OTHER_PRE_SPECIFIED | Proportion of Subjects Requiring a Relaxation of Hypoglycemic Agent | 24 weeks | Proportion of participants | NUMBER | |
| OTHER_PRE_SPECIFIED | Proportion of Subjects Requiring a Relaxation of Hypoglycemic Agent | Duration of study (168 weeks) | Proportion of participants | NUMBER | |
| OTHER_PRE_SPECIFIED | Proportion of Participants With Incidence of Hospitalization for Heart Failure | Duration of study (168 weeks) | Proportion of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02558296/outcomes